Saturday, June 12, 2021
Home Pharma

Pharma

Pharma

Kite’s Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Life Sciences Times - 0
SANTA MONICA, Calif.-- Kite, a Gilead Company (Nasdaq: GILD), announced today results from the primary analysis of ZUMA-3, a global, multicenter, single-arm, open-label Phase...
Read more
Pharma

Cytovale Begins Enrollment in FDA 510(k) Clinical Validation Study of IntelliSep Rapid Sepsis Test

Life Sciences Times - 0
SAN FRANCISCO-- Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune-mediated diseases, today announced the...
Read more
Pharma

Transgene and BioInvent Receive IND Approval from the U.S. FDA for BT-001, a Novel Oncolytic Virus for the Treatment of Solid Tumors

Life Sciences Times - 0
STRASBOURG, France & LUND, Sweden-- Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and...
Read more
Pharma

Geneoscopy Announces Publication of Peer-Reviewed Article Highlighting Effective Noninvasive Screening Test for Colorectal Cancer Prevention

Life Sciences Times - 0
ST. LOUIS-- Geneoscopy Inc. today announced publication of the peer-reviewed article, “Multitarget Stool RNA Test for Noninvasive Detection of Colorectal Neoplasias in a Multicenter,...
Read more
Pharma

Biogen and Ginkgo Bioworks Announce Collaboration Develop Novel Gene Therapy Manufacturing Platform

Life Sciences Times - 0
CAMBRIDGE, Mass. and BOSTON-- Biogen and Ginkgo Bioworks today announced a gene therapy collaboration. Together, the companies aim to redefine the industry standard for...
Read more
Pharma

Libtayo® receives positive CHMP opinion for the treatment in Europe of two advanced cancers

Life Sciences Times - 0
Libtayo has been recommended for approval in the first-line treatment of certain patients with advanced non-small cell lung cancer whose tumors have ≥50% PD-L1...
Read more
Pharma

Moderna and South Korea Explore Collaboration on mRNA Vaccines

Life Sciences Times - 0
CAMBRIDGE, Mass.-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Understanding (MoU) with...
Read more
Pharma

PPD Opens Multipurpose Clinical Research Laboratory in Suzhou, China

Life Sciences Times - 0
SUZHOU, China-- PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, held a grand opening ceremony for its new multipurpose laboratory in Suzhou,...
Read more
Pharma

BeiGene Announces Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy

Life Sciences Times - 0
CAMBRIDGE, Mass. & BEIJING-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...
Read more
Pharma

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY

Life Sciences Times - 0
NEW YORK & MAINZ, Germany-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC)...
Read more
Pharma

Biomax Informatics : Universities use NeuroXM™ to study the connectome in drug-resistant epilepsy

Life Sciences Times - 0
PLANEGG, Germany-- Using Biomax Informatics' NeuroXM knowledge management platform, scientists from the Universities of Nottingham, Newcastle, Qingdao, Shanghai and Munich have studied the change...
Read more
Pharma

Deerfield Management and Baylor College of Medicine Announce Blue Square Discoveries to Advance Novel Therapeutic Treatments

Life Sciences Times - 0
NEW YORK-- Deerfield Management Company (Deerfield), a healthcare investment management firm focused on advancing healthcare through investment, information and philanthropy, and Baylor College of...
Read more
123...10Page 1 of 10
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv